This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Belli, B Articles by Fan, H Search for Related Content PubMed PubMed Citation Articles by Belli, B Articles by Fan, H

 Previous Article  |  Next Article 

J Virol. 1994 November; 68(11): 6883-6889

The leukemogenic potential of an enhancer variant of Moloney murine leukemia virus varies with the route of inoculation.

Department of Molecular Biology, University of California, Irvine 92717.

ABSTRACT

We previously showed that the Mo+PyF101 variant of Moloney murine leukemia virus (M-MuLV) is poorly leukemogenic when inoculated subcutaneously (s.c.) into neonatal mice. We recently found that intraperitoneal (i.p.) inoculation of neonatal mice with the same virus significantly enhanced its leukemogenicity. In this study, infections of neonatal mice by the two different routes of inoculation were compared. We studied replication of the virus in vivo to identify critical preleukemic events. These would be observed in mice inoculated i.p. by Mo+PyF101 M-MuLV but not when inoculation was s.c. Infectious center assays indicated that regardless of the route of inoculation, Mo+PyF101 M-MuLV showed delayed infection of the thymus compared with wild-type M-MuLV. On the other hand, i.p.-inoculated mice showed more rapid appearance of infectious centers in the bone marrow than did s.c.-inoculated animals. Thus, the enhanced leukemogenicity of i.p. inoculation correlated with efficient early infection of the bone marrow and not with early infection of the thymus. These results suggest a role for bone marrow infection for efficient leukemogenesis in Mo+PyF101 M-MuLV-infected mice. Consistent with this notion, if bone marrow infection was decreased by injecting 10- to 12-day-old animals i.p., leukemogenicity resembled that of s.c. inoculation. Thus, two cell types that are critical for the induction of efficient leukemia were implicated. One cell delivers virus from the site of s.c. inoculation (the skin) to the bone marrow and is apparently restricted for Mo+PyF101 M-MuLV replication. The second cell is in the bone marrow, and its early infection is required for efficient leukemogenesis.

This article has been cited by other articles:

• Rulli, K., Lenz, J., Levy, L. S. (2002). Disruption of Hematopoiesis and Thymopoiesis in the Early Premalignant Stages of Infection with SL3-3 Murine Leukemia Virus. J. Virol. 76: 2363-2374 [Abstract] [Full Text]  
• Lander, J. K., Chesebro, B., Fan, H. (1999). Appearance of Mink Cell Focus-Inducing Recombinants during In Vivo Infection by Moloney Murine Leukemia Virus (M-MuLV) or the Mo+PyF101 M-MuLV Enhancer Variant: Implications for Sites of Generation and Roles in Leukemogenesis. J. Virol. 73: 5671-5680 [Abstract] [Full Text]  
• Bonzon, C., Fan, H. (1999). Moloney Murine Leukemia Virus-Induced Preleukemic Thymic Atrophy and Enhanced Thymocyte Apoptosis Correlate with Disease Pathogenicity. J. Virol. 73: 2434-2441 [Abstract] [Full Text]  
• Okimoto, M. A., Fan, H. (1999). Moloney Murine Leukemia Virus Infects Cells of the Developing Hair Follicle after Neonatal Subcutaneous Inoculation in Mice. J. Virol. 73: 2509-2516 [Abstract] [Full Text]  
• Okimoto, M. A., Fan, H. (1999). Identification of Directly Infected Cells in the Bone Marrow of Neonatal Moloney Murine Leukemia Virus-Infected Mice by Use of a Moloney Murine Leukemia Virus-Based Vector. J. Virol. 73: 1617-1623 [Abstract] [Full Text]  
• Uittenbogaart, C. H., Law, W., Leenen, P. J. M., Bristol, G., van Ewijk, W., Hays, E. F. (1998). Thymic Dendritic Cells Are Primary Targets for the Oncogenic Virus SL3-3. J. Virol. 72: 10118-10125 [Abstract] [Full Text]  
• Starkey, C. R., Lobelle-Rich, P. A., Granger, S., Brightman, B. K., Fan, H., Levy, L. S. (1998). Tumorigenic Potential of a Recombinant Retrovirus Containing Sequences from Moloney Murine Leukemia Virus and Feline Leukemia Virus. J. Virol. 72: 1078-1084 [Abstract] [Full Text]